By Bill Galluccio
Photo: Getty Images
The Food and Drug Administration is preparing to add a warning about a rare side effect that may occur after receiving Johnson & Johnson s COVID-19 vaccine. According to a report by the
While health officials said the syndrome is rare, people who received Johnson & Johnson s vaccine are three to five times more likely to develop the condition compared to the general population.
The FDA still believes the benefits of the vaccine outweigh the risks that people may develop Guillain-Barré syndrome. Most people who contract the syndrome make a full recovery, though some people suffer permanent nerve damage.
By Bill Galluccio
Photo: Getty Images
The Food and Drug Administration is preparing to add a warning about a rare side effect that may occur after receiving Johnson & Johnson s COVID-19 vaccine. According to a report by the
While health officials said the syndrome is rare, people who received Johnson & Johnson s vaccine are three to five times more likely to develop the condition compared to the general population.
The FDA still believes the benefits of the vaccine outweigh the risks that people may develop Guillain-Barré syndrome. Most people who contract the syndrome make a full recovery, though some people suffer permanent nerve damage.
FDA reports Johnson & Johnson vaccine raises risk of rare nerve syndrome
Photo credit: Shutterstock.com / Andrey Popov
Johnson & Johnson‘s coronavirus vaccine has suffered yet another setback with the Food and Drug Administration reporting that receiving the vaccine can lead to an increased risk of developing a rare neurological condition known as Guillain-Barré syndrome. While the chance of developing the syndrome is low, receivers of the Johnson & Johnson vaccine are 3 to 5 times more likely to develop the condition than those who have not received the Johnson & Johnson vaccine. Around 100 suspected cases have been identified among those who received the Johnson & Johnson vaccine. Fortunately, most who develop the condition recover.
By Bill Galluccio
Photo: Getty Images
The Food and Drug Administration is preparing to add a warning about a rare side effect that may occur after receiving Johnson & Johnson s COVID-19 vaccine. According to a report by the
While health officials said the syndrome is rare, people who received Johnson & Johnson s vaccine are three to five times more likely to develop the condition compared to the general population.
The FDA still believes the benefits of the vaccine outweigh the risks that people may develop Guillain-Barré syndrome. Most people who contract the syndrome make a full recovery, though some people suffer permanent nerve damage.
By Bill Galluccio
Photo: Getty Images
The Food and Drug Administration is preparing to add a warning about a rare side effect that may occur after receiving Johnson & Johnson s COVID-19 vaccine. According to a report by the
While health officials said the syndrome is rare, people who received Johnson & Johnson s vaccine are three to five times more likely to develop the condition compared to the general population.
The FDA still believes the benefits of the vaccine outweigh the risks that people may develop Guillain-Barré syndrome. Most people who contract the syndrome make a full recovery, though some people suffer permanent nerve damage.